Related Experiment Video
Updated: Feb 8, 2026
06:24
Minimal Erythema Dose MED Testing
Published on: May 28, 2013
42.9K
Diabetes in the elderly: Matching meds to needs
Barbara Keber1, Jennifer Fiebert1
1Hofstra Northwell School of Medicine, Northwell Health, Glen Cove, NY, USA.
The Journal of Family Practice
|July 11, 2018
Summary
Elderly patients with insulin resistance need personalized treatment. Age-related decline in beta-cell function and other diseases complicate management, requiring tailored therapeutic approaches.
Area of Science:
- Gerontology
- Endocrinology
- Metabolic Diseases
Background:
- Insulin resistance is a significant metabolic challenge in elderly individuals.
- Age-related decline in pancreatic beta-cell function exacerbates insulin resistance.
- Concomitant diseases in older adults further complicate metabolic management.
Purpose of the Study:
- To highlight the complex therapeutic considerations for elderly patients with insulin resistance.
- To emphasize the need for personalized treatment strategies in this demographic.
Main Methods:
- This study synthesizes current research on insulin resistance in aging.
- It reviews the impact of age-related physiological changes on glucose metabolism.
- It considers the influence of comorbidities on treatment efficacy.
Main Results:
- Elderly patients present unique challenges due to combined insulin resistance and reduced beta-cell reserve.
- Age-related factors and comorbidities necessitate individualized treatment plans.
- Standard treatment protocols may not be optimal for older adults.
Conclusions:
- Personalized therapeutic strategies are essential for managing insulin resistance in the elderly.
- A comprehensive approach considering age-related changes and comorbidities is crucial for effective treatment.
Related Concept Videos
01:17Sign Test for Matched Pairs
419
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
419
01:20Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
01:09Wilcoxon Signed-Ranks Test for Matched Pairs
501
The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
501
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
506
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K